Seer, Inc. ( (SEER) ) has released its Q3 earnings. Here is a breakdown of the information Seer, Inc. presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Seer, Inc., a leader in deep, unbiased proteomics, offers advanced solutions for biological insights through its Proteograph Product Suite, catering to the research sector.
In its third-quarter 2025 financial report, Seer, Inc. announced a revenue of $4.1 million, marking a modest increase from the previous year. The company highlighted a record number of third-party publications and significant demand for its Proteograph ONE workflow, underscoring its growing influence in the proteomics field.
Key financial metrics revealed a gross profit of $2.1 million with a 51% gross margin. Operating expenses saw a notable decrease to $21.5 million, driven by reduced stock-based compensation and other business costs. Despite these improvements, the company reported a net loss of $18.2 million, a reduction from the previous year’s $21.3 million loss. Seer ended the quarter with a strong cash position of $251.2 million.
Looking ahead, Seer maintains its revenue guidance for 2025, expecting growth between $17 million and $18 million, reflecting a 24% increase over 2024. The company’s management remains optimistic about the continued adoption of its technologies and its strategic direction in the proteomics market.